Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Pulmonx Corporation LUNG

Healthcare Medical Devices
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral... see more

Current News (NDAQ:LUNG)

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 3, 2025

Pulmonx Reports Third Quarter 2025 Financial Results

GlobeNewswire November 12, 2025

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

GlobeNewswire October 27, 2025

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

GlobeNewswire October 15, 2025

Pulmonx to Participate in September Investor Conferences

GlobeNewswire August 26, 2025

Pulmonx Reports Second Quarter 2025 Financial Results

GlobeNewswire July 30, 2025

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

GlobeNewswire July 29, 2025

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

GlobeNewswire July 16, 2025

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

GlobeNewswire May 28, 2025
View More News ››

Opinion & Analysis (NDAQ:LUNG)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LUNG)

Buy buddy buy because it's taking off this morning.

Otherwise FOMO
coolfooldumbguy - October 28, 2025

Using technical analysis for this one.

This stock was a good buy for me in the pre market action this morning and it is going up
coolfooldumbguy - February 20, 2025

PULMONX: BREATH OF FRESH AIR FOR LUNG DISEASE PATIENTS

$LUNG Excited to share an article about Pulmonx Corp (NASDAQ: LUNG), a global leader in minimally invasive treatments...
AviseAnalytics - June 27, 2023
View more Bullboard ››

Sranan Gold Corp.

Sranan Gold Corp.

Sranan Gold Corp. develops, acquires, and explores mineral properties in Canada. The company primarily explores gold deposits ...
View More »

Podcasts